Table 6: The influence of degree of macrovesicular steatosis on protective effects of sevoflurane preconditioning.

Macrovesicular steatosisIncidence of EAD, %Fisher’s exact test, two-tailed value
Sevoflurane groupControl group

None (0%)11,1 (1 of 9)11,1 (1 of 9)1,000
Mild (1–30%)18,8 (3 of 16)60,0 (9 of 15)0,029
Moderate (31–60%)20,0 (1 of 5)83,3 (5 of 6)0,080

EAD: early allograft dysfunction.